Cardiol Therapeutics
CRDL • NASDAQ
Cardiol Therapeutics is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David G. Elsley, with a market cap of $154.1M.
Market Cap$154.1M
Employees17.0
CEODavid G. Elsley
CountryCanada
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Cardiol Therapeutics FAQ
Common questions about Cardiol Therapeutics
Cardiol Therapeutics is scheduled to report earnings for Q1 2026 on May 13, 2026.
Cardiol Therapeutics has approximately 17 employees.